3 results on '"Gagnon JF"'
Search Results
2. [Rapid-eye-movement sleep disorders in Parkinson's disease].
- Author
-
Gagnon JF, Montplaisir J, and Bédard MA
- Subjects
- Antiparkinson Agents adverse effects, Antiparkinson Agents pharmacology, Antiparkinson Agents therapeutic use, Basal Ganglia drug effects, Basal Ganglia physiopathology, Brain Stem drug effects, Brain Stem physiopathology, Cholinergic Fibers physiology, Dopamine Agonists adverse effects, Dopamine Agonists pharmacology, Dopamine Agonists therapeutic use, Humans, Interneurons physiology, Models, Neurological, Motor Neurons physiology, Muscle Tonus drug effects, Muscle Tonus physiology, Neurodegenerative Diseases complications, Neurodegenerative Diseases physiopathology, Neurotransmitter Agents physiology, Parkinson Disease drug therapy, Polysomnography, REM Sleep Behavior Disorder physiopathology, Sleep Initiation and Maintenance Disorders etiology, Sleep Initiation and Maintenance Disorders physiopathology, Sleep, REM drug effects, Tegmentum Mesencephali drug effects, Tegmentum Mesencephali physiopathology, Parkinson Disease complications, REM Sleep Behavior Disorder etiology
- Abstract
During the past 10 years, there has been an increasing interest in the study of rapid-eye-movement (REM) sleep in neurodegenerative diseases and more particulary in Parkinson's disease (PD). This interest is justified by the strong association observed between these diseases and REM sleep behavior disorder (RBD). In the first section of this paper, a critical review of the literature on the presence of REM sleep disorders in PD is presented. Studies that show an association between PD and RBD are reviewed. Studies that report the presence of other REM sleep disorders in PD (short latency, abnormal length and/or proportion of REM sleep, increasing occurrence of hallucinations) are then discussed. Limitations of the criteria proposed by Rechtschaffen et Kales (1968) for the quantification of REM sleep are also presented. Some authors believe that dopaminergic (DA) agents used in the treatment of PD (levodopa, bromocriptine, pergolide, pramipexole and selegiline) could be a responsable factor for the occurence of REM sleep disorders observed in this disease. The literature concerning the impact of these DA agents on human REM sleep is therefore critically reviewed. It is concluded that DA agents cannot explain on their own the presence of REM sleep disorders in PD. Other causes, among which the disturbance of some neurochemical systems linked to the neuropathological process of the disease, must be considered in order to explain these REM sleep disorders. In the second section of this paper, we present the different pathophysiological hypotheses proposed to explain REM sleep disorders in PD, such as a dysfunction of the cholinergic, noradrenergic, serotonergic, dopaminergic or GABAergic neurons. Emphasis is placed on the role of cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei, structures shown to be particularly impaired in PD. Neurophysiological, neuroanatomical and neuropharmacological studies demonstrate that these neurons are strongly implicated in the different REM sleep parameters (muscular atonia, electroencephalographic desynchronisation, ponto-geniculo-occipital spikes). Finally, future research directions are proposed.
- Published
- 2002
3. [Deficit in suppression of interference in visual information processing by schizophrenic subjects].
- Author
-
Gagnon JF, Everett J, LaJeunesse C, Gosselin N, and Lavoie K
- Subjects
- Female, Humans, Male, Reaction Time, Attention, Inhibition, Psychological, Pattern Recognition, Visual, Schizophrenia diagnosis, Schizophrenic Psychology
- Abstract
Although many studies have indicated information processing deficits in schizophrenic patients, the precise nature and underlying causes of these deficits remain largely uncertain. One prominent hypothesis is that these patients show insufficient attentional inhibition. This deficit to inhibition has been linked to certain cognitive disorders in schizophrenic patients, including attention deficits, as well as to some clinical symptoms, especially those involving delusional thought, hallucinations,and poor contact with reality. The hypothesis of deficient attentional inhibition, although attractive in some ways, is difficult to work with, because it is not easy to directly measure "attentional inhibition". Several studies involving normal subjects have linked attentional inhibition with performance on a task demanding the suppression of distracting information: the presumption is that efficient attentional inhibition will permit rapid responses because the distracting information will be quickly suppressed, allowing undistracted processing of the target information. The present study measures schizophrenic patients' performance on a task demanding suppression of rapidly-presented visual information. An important methodological feature of this study is that performance is measured in terms of "percent correct responses" rather than the reaction time measures typically used in tasks demanding distractor suppression, such as Stroop-like selective attention tasks. Since reaction times are not considered, the results cannot be interpreted in terms of deficient response organization and execution. Schizophrenic (18) and normal (18) subjects underwent trials in which a visual target was the second of two stimuli presented in rapid succession. Interference produced by a non-target significantly impaired perception of the target for schizophrenic patients. This effect persisted longer in the schizophrenic subjects possibly because of deficient attentional inhibition.
- Published
- 2000
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.